Drew Watson
About Drew Watson
Drew Watson is the Sr. VP of Clinical Studies & Biostatistics with a distinguished career in biostatistics and genomics, known for leading the clinical trial for Oncotype DX.
Drew Watson Sr. VP of Clinical Studies & Biostatistics
Drew Watson currently serves as the Senior Vice President of Clinical Studies and Biostatistics. In this role, Watson is responsible for overseeing clinical studies and ensuring the integrity and accuracy of biostatistical methodologies applied within the organization. Watson's background in biostatistics and computational statistics positions him as a key figure in the development and implementation of data-driven strategies in clinical environments.
Drew Watson Education and Expertise
Drew Watson holds a B.S. in Statistics from California State University East Bay and an M.S. in Computational Statistics from Stanford University. Additionally, Watson earned an M.B.A. in Strategic Management from Golden State University and a PhD in Biostatistics from UCLA. This educational background provides a solid foundation for his expertise in biostatistics, computational statistics, and strategic management, contributing to his effectiveness in leading clinical studies and biostatistics initiatives.
Drew Watson Professional Background
Drew Watson has a rich professional history, having worked at Invitae, Genomic Health, Incyte Genomics, and Chiron Corporation. His experiences at these organizations have equipped him with extensive knowledge and skills in genomics, biostatistics, and clinical trials. Watson's career includes leading significant projects and driving forward initiatives that have had substantial impacts on clinical practices and patient outcomes.
Drew Watson Achievements in Clinical Trials
One of Drew Watson's notable achievements includes leading the pivotal clinical trial for Oncotype DX, a molecular diagnostic used for breast cancer recurrence risk assessment. This clinical trial played a critical role in gaining coverage for Oncotype DX by the Centers for Medicare and Medicaid Services (CMS), making it a landmark contribution to oncology diagnostics.
Drew Watson Publications and Patents
Drew Watson has published extensively in the fields of biostatistics, oncology, and genomics. His numerous publications contribute to the scientific community's understanding and advancements in these areas. Moreover, Watson holds multiple key U.S. patents in genomics, algorithm development, and personalized medicine, underscoring his innovative contributions to the field.